Pancreatic Ubap2 deletion regulates glucose tolerance, inflammation, and protection from cerulein-induced pancreatitis
Cancer Letters · 2023-12 · 578 · 216455
DOI: 10.1016/j.canlet.2023.216455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2023-12. Verfasst von Ram Vinod Roy und 14 weiteren Autor:innen. Beteiligte Einrichtung: Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Department of Pathology, The U…. Hauptthemen laut MEDLINE: Adenocarcinoma, Pancreatic Neoplasms, Pancreatitis, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
- Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
- Center for Cancer Prevention and Drug Development, Department of Medicine, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
- Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
- Peggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Department of Cell Biology, University of Oklahoma Health Science Center, Oklahoma City, OK, USA.
- Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Cancer Institute
- NIGMS
Zitieren
APA
Roy, R. V., Means, N., Rao, G., Asfa, S., Madka, V., Dey, A., Zhang, Y., Choudhury, M., Fung, K. M., Dhanasekaran, D. N., Friedman, J. E., Crawford, H. C., Rao, C. V., Bhattacharya, R., & Mukherjee, P. (2023). Pancreatic Ubap2 deletion regulates glucose tolerance, inflammation, and protection from cerulein-induced pancreatitis. Cancer Letters, 578, 216455. https://doi.org/10.1016/j.canlet.2023.216455
Vancouver
Roy RV, Means N, Rao G, Asfa S, Madka V, Dey A, et al. Pancreatic Ubap2 deletion regulates glucose tolerance, inflammation, and protection from cerulein-induced pancreatitis. Cancer Letters. 2023;578:216455. doi:10.1016/j.canlet.2023.216455
BibTeX
@article{Roy2023,
author = {Roy, Ram Vinod and Means, Nicolas and Rao, Geeta and Asfa, Sima and Madka, Venkateshwar and Dey, Anindya and Zhang, Yushan and Choudhury, Monalisa and Fung, Kar-Ming and Dhanasekaran, Danny N and Friedman, Jacob E and Crawford, Howard C and Rao, Chinthalapally V and Bhattacharya, Resham and Mukherjee, Priyabrata},
title = {Pancreatic Ubap2 deletion regulates glucose tolerance, inflammation, and protection from cerulein-induced pancreatitis},
journal = {Cancer Letters},
year = {2023},
volume = {578},
pages = {216455},
doi = {10.1016/j.canlet.2023.216455}
}
EUVIMED